Targeting LINC02613 to inhibit oral squamous cell carcinoma metastasis and progression via the rehabilitation of LCP1 ubiquitination
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2025.112253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Qiming Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China; Guangdong Pr…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Mouth Neoplasms, Ubiquitination, Carcinoma, Squamous Cell. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Shenzhen Science and Technology Innovation Program, Science and Technology Planning Project of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Lymph node metastasis of tumors is an important adverse factor affecting the long-term prognosis of patients with oral squamous cell carcinoma (OSCC). In recent years, the abnormal expression of long noncoding RNAs (lncRNAs) has gained attention because of their significant role in regulating tumor biological behaviors. Exploring key regulatory targets of lncRNAs in OSCC metastasis could provide new diagnostic and therapeutic targets for predicting and intervening in metastasis. In this study, we identified and validated LINC02613 as a critical lncRNA with a significant regulatory role in promoting OSCC metastasis and progression. Further research revealed that LINC02613 interacts with lymphocyte cytosolic protein 1 (LCP1), shielding its ubiquitination site and interfering with its normal ubiquitination degradation process, thereby promoting OSCC metastasis and progression. Using pH-responsive nanoparticles (PLGA-Dlink) loaded with siLINC02613 for targeted delivery in vivo and in vitro, we successfully inhibited OSCC metastasis and progression, providing a new potential therapeutic approach for OSCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regula…
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen Universi…
- Department of Oral and Maxillofacial Surgery, Hospital of Stomatology Zhongshan City, Zhongshan 528400, China.
- Department of Prosthodontics and Implantology, Shenzhen University Affiliated Shenzhen Stomatology Hospital, Shenzhen 518000, China.
- Department of Oral and Maxillofacial Surgery, Hospital of Stomatology Zhongshan City, Zhongshan 528400, China. Electronic address: 491781534@qq.com.
- Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China. Electronic address: hzhquan@mail.sysu.edu.cn.
Förderung
- Shenzhen Science and Technology Innovation Program
- Science and Technology Planning Project of Guangdong Province
- National Natural Science Foundation of China
- Sun Yat-sen University
- Guangzhou Municipal Science and Technology Program key projects
- Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-sen University
Zitieren
APA
Jiang, Q., Lu, N., Chen, R., Xu, Z., Sun, H., Xu, T., Su, K., Huang, Z., & Huang, Z. (2026). Targeting LINC02613 to inhibit oral squamous cell carcinoma metastasis and progression via the rehabilitation of LCP1 ubiquitination. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112253
Vancouver
Jiang Q, Lu N, Chen R, Xu Z, Sun H, Xu T, et al. Targeting LINC02613 to inhibit oral squamous cell carcinoma metastasis and progression via the rehabilitation of LCP1 ubiquitination. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2025.112253
BibTeX
@article{Jiang2026,
author = {Jiang, Qiming and Lu, Nan and Chen, Rui and Xu, Zhijie and Sun, Haipeng and Xu, Tianshu and Su, Kui and Huang, Zixian and Huang, Zhiquan},
title = {Targeting LINC02613 to inhibit oral squamous cell carcinoma metastasis and progression via the rehabilitation of LCP1 ubiquitination},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2025.112253}
}
EUVIMED